X.T.L. Biopharmaceuticals Ltd. - ADR

XTLB

Get informed when a big investor buys or sells

Market Cap$5.77M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
X.T.L. Biopharmaceuticals Ltd. - ADR	-4.2	-	-19%	0.6	-

$6.82

Current Fair Value

201.9% upside

Undervalued by 201.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$5.77 Million
Enterprise Value	$5.56 Million
Dividend Yield	$- (-)
Earnings per Share	$-9.6
Beta	0.71
Outstanding Shares	105,163

Return

Return on Equity	-18.90%
Return on Assets	-12.01%
Return on Invested Capital	-31.75%

Valuation & Multiples

P/E Ratio	-4.21
PEG	41.19
Price to Sales	0.57
Price to Book Ratio	0.04
Enterprise Value to Revenue	12.32
Enterprise Value to EBIT	-2.76
Enterprise Value to Net Income	-6
Total Debt to Enterprise	0.03
Debt to Equity	0.03

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

April 29, 2026

EPS Estimate

Average shareholder expectation

Revenue Estimate

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.00000%
Total Calls	-
Total Puts	-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	69.13%▼ 9.25%
Total Invested	$175,378▼ 8.12%
Investors Holding	60%

ESG Score